PDL BioPharma, Inc. (PDLI) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Income before income taxes: 28.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income before income taxes: 28.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q2 adjusted EPS of $0.39, $0.01 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $122.1 million versus the consensus estimate of $123.25 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
